加巴丁类药物和部骨折的风险
Miriam T Y Leung1, Justin P Turner1,2,3,4, Clara Marquina1
1Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.
gabapentinoid 的使用会增加关节骨折的风险,特别是在脆弱的个体和患有慢性脏病的人中. 这突显了脆弱性是 gabapentinoid相关骨折的关键风险因素.
科学领域:
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- gabapentinoid 的使用正在增加,特别是在易受部骨折的老年人中.
- 老年人群经常患有慢性病 (CKD) 和虚弱等并发症,增加了脆弱性.
研究的目的:
- 为了检查 gabapentinoid 使用和关节骨折风险之间的关联.
- 将这种风险按年龄,脆弱状态和CKD病史分层.
主要方法:
- 在澳大利亚因关节骨折住院的患者中进行了个案-个案-时间-控制研究 (2013-2018).
- 条件后勤回归分析了在骨折前给出 gabapentinoid 的情况.
- 使用医院脆弱性风险评分 (HFRS) 来评估脆弱性.
主要成果:
- 在调整后,开放 gabapentinoid 与部骨折的几率增加了 30% (OR,1.30;95% CI,1.07-1.57).
- 这种关联在HFRS得分≥5 (OR,1.75) 和CKD (OR,2.41) 的患者中更强.
结论:
- gabapentinoid 的使用与部骨折的更高风险有关.
- 虚弱和CKD显著放大了这种风险,强调了它们在临床决策中的重要性.
更多相关视频
06:31Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain
Published on: August 8, 2019
06:58Method and Instrumented Fixture for Femoral Fracture Testing in a Sideways Fall-on-the-Hip Position
Published on: August 17, 2017
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
